10.1016/j.cell.2011.10.026 17
Scientists have developed a new compound called ipamorelin that can stimulate the release of growth hormone (GH)
The discomfort typically manifests as stiffness upon waking or after periods of inactivity
Onset of macroalbuminuria during the EXSCEL trial was less frequent with exenatide than with placebo but the difference was not statistically significant (adjusted HR = 0.84, 95% CI = 0.701.07)
In the wake of the Trump deal, the GLP-1 market is poised to evolve with broader adoption of oral formulations, ongoing price competition, and more payer-level formulary adjustments that will influence long-term affordability and access
Its incumbent on employers now to start navigating how to cover the drugs in the most cost-effective manner. Editors Note: Additional Content For more information and resources related to this article, see the pages below, which offer quick access to all WorldatWork content on these topics: